Health Care [ 5/12 ] | Biotechnology [ 8/73 ]
NASDAQ | Common Stock
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.
It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics.
The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 30, 25 | 0.00 Increased by +100.00% | -0.84 Increased by +100.00% |
| Jul 28, 25 | -0.97 Decreased by -38.57% | -0.94 Decreased by -3.19% |
| May 22, 25 | -1.05 Decreased by -29.63% | -0.84 Decreased by -25.54% |
| Mar 3, 25 | -0.88 Increased by +19.27% | -0.91 Increased by +3.51% |
| Nov 4, 24 | -0.96 Increased by +2.75% | -0.71 Decreased by -35.61% |
| Aug 1, 24 | -0.70 Increased by +35.19% | -0.72 Increased by +2.78% |
| May 2, 24 | -0.81 Decreased by -3.85% | -0.80 Decreased by -1.25% |
| Mar 5, 24 | -1.09 Decreased by -47.30% | -0.92 Decreased by -18.48% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 0.00 Decreased by N/A% | -110.86 M Decreased by -70.28% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -115.36 M Decreased by -75.72% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 1.57 M Decreased by -58.50% | -89.54 M Decreased by -34.37% | Decreased by -5.70 K% Decreased by -223.79% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -97.13 M Decreased by -61.31% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -65.10 M Decreased by -0.31% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -65.65 M Decreased by -54.48% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 3.79 M Increased by +N/A% | -66.64 M Decreased by -77.65% | Decreased by -1.76 K% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -60.21 M Decreased by -48.70% | Decreased by N/A% Decreased by N/A% |